Evidence map›Paper›PMID 29879542›Full record

ArticleVirology2018

Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy.

Feiyu Hong, Jana L Jacobs, Evgenia Aga, Anthony R Cillo, Elizabeth Fyne, Dianna L Koontz, Lu Zheng, John W Mellors

Abstract read
In one paragraph

Article in Virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Persistent HIV-1 transcription in CD4Journal of virus eradication · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Feiyu HongUniversity of Pittsburgh School of Medicine, Division of Infectious Diseases, 3550 Terrace Street, Scaife Hall, Suite 818, Pittsburgh, PA 15261, United States.
Jana L JacobsUniversity of Pittsburgh School of Medicine, Division of Infectious Diseases, 3550 Terrace Street, Scaife Hall, Suite 818, Pittsburgh, PA 15261, United States.
Evgenia AgaCenter for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
Anthony R CilloUniversity of Pittsburgh School of Medicine, Division of Infectious Diseases, 3550 Terrace Street, Scaife Hall, Suite 818, Pittsburgh, PA 15261, United States.
Elizabeth FyneUniversity of Pittsburgh School of Medicine, Division of Infectious Diseases, 3550 Terrace Street, Scaife Hall, Suite 818, Pittsburgh, PA 15261, United States.
Dianna L KoontzUniversity of Pittsburgh School of Medicine, Division of Infectious Diseases, 3550 Terrace Street, Scaife Hall, Suite 818, Pittsburgh, PA 15261, United States.
Lu ZhengCenter for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
John W MellorsUniversity of Pittsburgh School of Medicine, Division of Infectious Diseases, 3550 Terrace Street, Scaife Hall, Suite 818, Pittsburgh, PA 15261, United States. Electronic address: jwm1@pitt.edu.
University of Pittsburgh · USCancer Research And Biostatistics · US

Funding

Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)UM1AI068634 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Marlene Ann Cooper, Michael David Hughes · 2011 to 2026
$246.6M
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
Statistical and Data Management Center for the AIDS Clinical Trials GroupU01AI068634 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI HUGHES, MICHAEL DAVID · 2006 to 2010
$71.9M
NCI NIH HHS HHSN261200800001ENIAID NIH HHS U01 AI068634NIAID NIH HHS UM1 AI068634NIAID NIH HHS UM1 AI106701
6 · The paper itself

Abstract

The relationships between HIV-1 DNA copy number, proviral transcriptional activity, and residual plasma viremia in individuals off and on ART are not well defined. To address this, we performed a cross-sectional study of 12 viremic donors and 23 ART-treated virologically suppressed (plasma HIV-1 RNA<20 copies/ml) donors. We report a strong association between HIV-1 DNA copy number and HIV-1 transcriptional activity in blood that persists on suppressive ART, but not between transcriptional activity and the levels of persistent viremia on ART. The latter finding contrasts with that in viremic donors and suggests that most HIV transcription in donors on suppressive ART does not result in virion production. This uncoupling of proviral transcription and viremia warrants closer investigation.

Indexed as

DNA Copy Number VariationsAdultAnti-Retroviral AgentsCross-Sectional StudiesDNA, ViralFemaleHIV-1HIV InfectionsHumansMaleMiddle AgedProvirusesRNA, ViralTranscription, GeneticViral LoadViremiaAnti-Retroviral AgentsDNA, ViralRNA, ViralHIV-1 cureHIV-1 DNAHIV-1 persistenceHIV-1 reservoirHIV-1 RNAHIV-1 viremia

Identifiers

PMID29879542
PMCPMC6279608
OpenAlexW2805094276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.